Methodological considerations for ghrelin isoforms assay in clinical evaluation in anorexia nervosa.

Anorexia nervosa Appetite Ghrelin Immunoassay Pulsatile secretion

Journal

Comprehensive psychoneuroendocrinology
ISSN: 2666-4976
Titre abrégé: Compr Psychoneuroendocrinol
Pays: England
ID NLM: 101774169

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 17 02 2022
revised: 30 04 2022
accepted: 02 05 2022
entrez: 27 6 2022
pubmed: 28 6 2022
medline: 28 6 2022
Statut: epublish

Résumé

The growing interest concerning the role of metabolic sensors in various eating disorders requires the implementation of a strict methodology to collect, store and process blood samples in clinical studies. In particular, measurement of isoforms of the appetite-stimulating hormone, ghrelin, has been challenging in clinical settings. Indeed the acyl ghrelin (AG) isoform is rapidly degraded into desacyl ghrelin (DAG) by blood esterases, thus optimal conditions for the conservation of AG and accurate determination of AG/DAG ratio should be used. Here, we compared different protease inhibitors (Aprotinin, PHMB, AEBSF) during blood collection, increasing delays (0-180 min) before centrifugation, plasma supplementation with various HCl concentrations, storage durations of frozen plasma (8 and 447 days) and immunoenzyme-assay procedures (one-step

Identifiants

pubmed: 35757178
doi: 10.1016/j.cpnec.2022.100140
pii: S2666-4976(22)00031-5
pmc: PMC9227986
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100140

Informations de copyright

© 2022 The Author(s).

Déclaration de conflit d'intérêts

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Benoît de Grimaudet is working at Bertin Biotechnologies.

Références

Proc Natl Acad Sci U S A. 2008 Apr 29;105(17):6320-5
pubmed: 18443287
Clin Biochem. 2012 Jan;45(1-2):178-80
pubmed: 22100897
Front Horm Res. 2014;42:163-74
pubmed: 24732934
Endocrinology. 2010 Oct;151(10):4765-75
pubmed: 20685872
J Clin Med. 2020 Aug 28;9(9):
pubmed: 32872151
Bioanalysis. 2012 Oct;4(20):2447-55
pubmed: 23157354
Am J Psychiatry. 2017 Sep 1;174(9):850-858
pubmed: 28494655
Front Neurosci. 2017 Apr 20;11:211
pubmed: 28473748
Clin Endocrinol (Oxf). 2015 Jan;82(1):142-6
pubmed: 24810977
Biol Psychiatry. 2012 Sep 1;72(5):347-53
pubmed: 22458951
J Clin Endocrinol Metab. 2008 May;93(5):1980-7
pubmed: 18349056
J Nutr. 2005 May;135(5):1320-5
pubmed: 15867333
J Psychiatry Neurosci. 2020 Mar 04;45(4):253-261
pubmed: 32129584
Horm Metab Res. 2010 Jul;42(8):595-8
pubmed: 20411479
Peptides. 2011 Nov;32(11):2274-82
pubmed: 21530598
J Neuroendocrinol. 2016 Feb;28(2):12349
pubmed: 26661382
Endocrinology. 2009 Nov;150(11):5113-8
pubmed: 19819958

Auteurs

C Tezenas du Montcel (C)

Université Paris Cité, UMR-S 1266 INSERM, Institut de Psychiatrie et Neuroscience de Paris (IPNP), F-75014, Paris, France.

P Duriez (P)

Université Paris Cité, UMR-S 1266 INSERM, Institut de Psychiatrie et Neuroscience de Paris (IPNP), F-75014, Paris, France.
Clinique des Maladies Mentales et de L'Encéphale, GHU Paris Psychiatrie et Neurosciences, Hôpital Sainte-Anne, F-75014, Paris, France.

N Lebrun (N)

Université Paris Cité, UMR-S 1266 INSERM, Institut de Psychiatrie et Neuroscience de Paris (IPNP), F-75014, Paris, France.

D Grouselle (D)

Université Paris Cité, UMR-S 1266 INSERM, Institut de Psychiatrie et Neuroscience de Paris (IPNP), F-75014, Paris, France.

B de Grimaudet (B)

Bertin Technologies, F-78180, Montigny-le-Bretonneux, France.

R Dardennes (R)

Clinique des Maladies Mentales et de L'Encéphale, GHU Paris Psychiatrie et Neurosciences, Hôpital Sainte-Anne, F-75014, Paris, France.
Université Paris Cité, Paris, France.

J Epelbaum (J)

Université Paris Cité, UMR-S 1266 INSERM, Institut de Psychiatrie et Neuroscience de Paris (IPNP), F-75014, Paris, France.
UMR 7179 CNRS, MNHN, Adaptive Mechanism and Evolution (MECADEV), F-91800, Brunoy, France.

M Cuenca (M)

Centre de Recherche Clinique, GHU Paris Psychiatrie et Neurosciences, Hôpital Sainte-Anne, F-75014, Paris, France.

O Viltart (O)

Université Paris Cité, UMR-S 1266 INSERM, Institut de Psychiatrie et Neuroscience de Paris (IPNP), F-75014, Paris, France.
Université de Lille, SCALab UMR-CNRS 9193, PsySEF, F-59650, Villeneuve D'Ascq, France.

P Gorwood (P)

Université Paris Cité, UMR-S 1266 INSERM, Institut de Psychiatrie et Neuroscience de Paris (IPNP), F-75014, Paris, France.
Clinique des Maladies Mentales et de L'Encéphale, GHU Paris Psychiatrie et Neurosciences, Hôpital Sainte-Anne, F-75014, Paris, France.

V Tolle (V)

Université Paris Cité, UMR-S 1266 INSERM, Institut de Psychiatrie et Neuroscience de Paris (IPNP), F-75014, Paris, France.

Classifications MeSH